According to a market report by Lucintel, the future of the global viral vector manufacturing market looks promising with opportunities in the pharmaceutical & biopharmaceutical and research institute markets. The global viral vector manufacturing market is expected to reach an estimated $5,877 million by 2035 with a CAGR of 13.7% from 2026 to 2035. The major drivers for this market are the increasing demand for scalable manufacturing technologies, the growing investments in biotechnology companies, and the rising demand for government funding for life sciences.
A more than 150-page report to understand trends, opportunity and forecast in viral vector manufacturing market to 2035 by type (adenovirus, retrovirus, adeno-associated virus, lentivirus, plasmid DNA, and others), workflow (upstream manufacturing and downstream manufacturing), application (cell & gene therapy, vaccinology, and research & other applications), end use (pharmaceutical & biopharmaceutical, research institutes, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World).
Lucintel forecasts that, within the type category, adeno-associated virus is expected to witness higher growth over the forecast period.
Within the end use category, pharmaceutical & biopharmaceutical is expected to witness the highest growth.
Download sample by clicking on viral vector manufacturing market
In terms of region, APAC is expected to witness the highest growth over the forecast period.
Merck, Lonza, Fujifilm Diosynth Biotechnologies, Thermo Fisher Scientific, Cobra Biologics, Catalent, Wuxi Biologics, Takara Bio, Waisman Biomanufacturing, Genezen Laboratories are the major suppliers in the viral vector manufacturing market.
This unique research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or write us at [email protected] to get access of more than 1000 reports at fraction of cost visit Lucintel's Analytics Dashboard.
About Lucintel
At Lucintel, we offer solutions for you growth through game changer ideas and robust market & unmet needs analysis. We are based in Dallas, TX and have been a trusted advisor for 1,000+ clients for over 20 years. We are quoted in several publications like the Wall Street Journal, ZACKS, and the Financial Times.
Contact:
Roy Almaguer
Lucintel
Dallas, Texas, USA
Email: [email protected]
Tel. +1-972-636-5056
Explore Our Latest Publications
Sensor Fusion System Market
SIP Bioreactor Market
Skin Microbiome Modulation Market
Smoke Ventilation System Market
Space Utilization Sensor Market